Overview

Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading

Status:
Withdrawn
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
There is gender dimorphism in cardiovascular risk, with men at higher risk than women. However, the fundamental basis for the protective effect of female sex remains unclear. Recent data implicate the natriuretic peptide (NP) system as an important determinant of blood pressure. Also, NP levels are twice as high in women of reproductive age than in men, and gonadal steroids are important determinants of circulating NPs. These are the marked, but poorly understood differences in the NP status between men and women. The investigators hypothesize that gonadal steroids regulate NP release, specifically that testosterone inhibits and estrogen activates the NP axis, leading to differences in both resting NP levels and dynamic responses of the NP, RAAS, and kidneys to acute and chronic salt loading. Understanding the basis for gender differences in NP function should provide important insights regarding mechanisms underlying hypertension in men versus women.
Phase:
Early Phase 1
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Anastrozole
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Leuprolide
Methyltestosterone
Polyestradiol phosphate
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate